Pharmacotherapy for squamous-cell carcinoma of the head and neck.
about
Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry.Array CGH analysis of the rare laryngeal basaloid squamous cell carcinoma: a case report.Targeted therapy in head and neck cancer.Translational genomics and head and neck cancer: toward precision medicine.Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis.
P2860
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@en
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@nl
type
label
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@en
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@nl
prefLabel
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@en
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@nl
P2093
P2860
P1476
Pharmacotherapy for squamous-cell carcinoma of the head and neck.
@en
P2093
Andreas Dietz
Giorgos Papaspyrou
Jochen A Werner
P2860
P304
P356
10.1517/14656566.2011.523698
P407
P577
2011-02-01T00:00:00Z